Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Evaluation of GenoFlow DR-MTB Array Test for Detection of Rifampin and Isoniazid Resistance in Mycobacterium tuberculosis.

Journal of clinical microbiology - 1 Apr 2016

Molina-Moya B, Kazdaglis G, Lacoma A, Prat C, Gómez A, Villar-Hernández R, García-García E, Haba L, Maldonado J, Samper S, Ruiz-Manzano J, Domínguez J

Abstract excerpt

The aim of this study was to evaluate the GenoFlow DR-MTB array test (DiagCor Bioscience, Hong Kong) on 70 cultured isolates and 50 sputum specimens. The GenoFlow array test showed good sensitivity and specificity compared to the phenotypic Bactec 460TB. This array accurately detected mutations inrpoB,katG, andinhAassociated with resistance to rifampin and isoniazid.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antitubercular Agents
Share to Catalase

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genotyping Techniques

Share to Isoniazid

Share to Mycobacterium tuberculosis

Share to Oxidoreductases

Share to Rifampin

Share to RNA Polymerase II

Source

Open in PubMed Open full text

Identifiers

PMID: 26865688
DOI: 10.1128/JCM.03341-15
PMCID: PMC4809924

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Evaluation of GenoFlow DR-MTB Array Test for Detection of Rifampin and Isoniazid Resistance in Mycobacterium tuberculosis.PMID 26865688Read ↗

Evaluation of the CombiChip Mycobacteria Drug-Resistance detection DNA chip for identifying mutations associated with resistance to isoniazid and rifampin in Mycobacterium tuberculosis.Semantic proximity Read ↗

Rapid genotypic detection of rifampin- and isoniazid-resistant Mycobacterium tuberculosis directly in clinical specimens.Semantic proximity Read ↗

Genotypic assessment of drug-resistant tuberculosis in Baghdad and other Iraqi provinces using low-cost and low-density DNA microarrays.Semantic proximity Read ↗

Detection of mutations associated with isoniazid and rifampin resistance in Mycobacterium tuberculosis isolates from Samara Region, Russian Federation.Semantic proximity Read ↗

Comparison of a conventional antimicrobial susceptibility assay to an oligonucleotide chip system for detection of drug resistance in Mycobacterium tuberculosis isolates.Semantic proximity Read ↗

A novel genotypic test for rapid detection of multidrug-resistant Mycobacterium tuberculosis isolates by a multiplex probe array.Semantic proximity Read ↗

Evaluation of the TB-Biochip Oligonucleotide Microarray System for Rapid Detection of Rifampin Resistance in <i>Mycobacterium tuberculosis</i>Semantic proximity Read ↗

Use of a mycobacteriophage-based assay for rapid assessment of susceptibilities of Mycobacterium tuberculosis isolates to isoniazid and influence of resistance level on assay performance.Semantic proximity Read ↗

Solid-phase sequence scanning for drug resistance detection in tuberculosis.Semantic proximity Read ↗

The use of macroarrays for the identification of MDR Mycobacterium tuberculosis.Semantic proximity Read ↗

Detection of mutations in Mycobacterium tuberculosis genome determining resistance to fluoroquinolones by hybridization on biological microchips.Semantic proximity Read ↗

Detection of streptomycin and quinolone resistance in Mycobacterium tuberculosis by a low-density DNA array.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.